Joanne Wuensch
Stock Analyst at Citigroup
(2.44)
# 870
Out of 5,240 analysts
397
Total ratings
60.91%
Success rate
23.80%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Tandem Diabetes Care | Maintains: Buy | 57 50 | 35.79 | 39.7% | 13 | Dec 11, 2024 | |
Stryker | Maintains: Strong Buy | 411 450 | 362.71 | 24.07% | 12 | Dec 11, 2024 | |
Sight Sciences | Maintains: Neutral | 6 5 | 3.15 | 46.03% | 9 | Dec 11, 2024 | |
Penumbra | Maintains: Neutral | 200 245 | 253.66 | -3.41% | 24 | Dec 11, 2024 | |
Nevro | Maintains: Neutral | 6 5 | 3.67 | 36.24% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 175 | 144.67 | 20.96% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 567 640 | 538.11 | 18.93% | 15 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 130 145 | 138.55 | 4.66% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 283 310 | 267.3 | 15.97% | 13 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 83 | 71.02 | 16.87% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 91 | 79.23 | 14.86% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 37 35 | 30.61 | 14.34% | 18 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 98 107 | 95.55 | 11.98% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 8 | 6.85 | 9.49% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 22 | 17.23 | 27.68% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 132 162 | 148.27 | 9.26% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 116 115 | 89.03 | 29.17% | 17 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 22 | 21.91 | 0.41% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 85 92 | 85.13 | 8.07% | 16 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 45 50 | 33.16 | 50.78% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 135 110 | 99.01 | 11.1% | 17 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 94 85 | 79.91 | 6.37% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 134 120 | 104.65 | 14.67% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 88 103 | 84.09 | 22.49% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 126 128 | 113.03 | 13.24% | 19 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 35 8 | n/a | n/a | 11 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 63 52 | n/a | n/a | 10 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 220 250 | 235.82 | 6.01% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 67 69 | 82.68 | -16.55% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 30 | n/a | n/a | 6 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 109 127 | 228.56 | -44.43% | 5 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 65 40 | n/a | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 245 0 | n/a | n/a | 2 | Apr 25, 2017 |